Zepbound
Brand tirzepatide (Eli Lilly)
FDA-approved tirzepatide for chronic weight management and obstructive sleep apnea with obesity.
About Zepbound
Zepbound is approved for adults with obesity, or overweight with a weight-related condition, along with diet and exercise, and for moderate to severe obstructive sleep apnea in adults with obesity.
Read the full Tirzepatide guide: research, safety and sources →
How it works
- Complete a short online visit. Answer health questions on our telehealth partner's secure site. Some treatments need lab work first.
- A licensed provider reviews it. They decide whether Zepbound is safe and appropriate for you and may message you with questions.
- If prescribed, it ships to you from a licensed U.S. pharmacy, with ongoing check-ins and refills through your provider.
Important safety information
Carries a boxed warning: in rodents it caused thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Nausea, vomiting, diarrhea and constipation are common. Pancreatitis, gallbladder problems, kidney problems and low blood sugar (with other diabetes medicines) can occur. Not for use during pregnancy.
This is not a complete list. Your provider will review your health history, medicines and allergies before prescribing, and the pharmacy includes the full prescribing information.